- €1.65bn
- €2.22bn
- €684.60m
- 28
- 35
- 47
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 419 | 484 | 516 | 516 | 685 |
Cost of Revenue | |||||
Gross Profit | 129 | 130 | 80.7 | 125 | 280 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 420 | 486 | 563 | 533 | 541 |
Operating Profit | -1.2 | -1.3 | -47.1 | -16.6 | 144 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.3 | -30 | -62.6 | -30.8 | 106 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.7 | -31.4 | -63.3 | -31.6 | 127 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -4.7 | -31.4 | -63.3 | -31.6 | 127 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.81 | -32.2 | -65 | -32.5 | 127 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.076 | -0.83 | -1.69 | -0.821 | 1.53 |
Dividends per Share |